We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients (MBC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02018419
Recruitment Status : Withdrawn (changing indication from breast cancer to metastatic colorectal cancer)
First Posted : December 23, 2013
Last Update Posted : April 3, 2015
Sponsor:
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : March 2016
  Estimated Study Completion Date : March 2017
Publications: